|
C20ORF4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.41160000039542E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.81422999999681E-05 |
| Normal-vs-Stage2 |
9.952600E-04 |
| Normal-vs-Stage3 |
5.816600E-01 |
| Normal-vs-Stage4 |
8.403900E-03 |
| Stage1-vs-Stage2 |
4.045800E-01 |
| Stage1-vs-Stage3 |
1.913450E-01 |
| Stage1-vs-Stage4 |
3.982600E-01 |
| Stage2-vs-Stage3 |
7.812100E-02 |
| Stage2-vs-Stage4 |
8.051400E-01 |
| Stage3-vs-Stage4 |
1.587420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.95635999999944E-05 |
| Normal-vs-AfricanAmerican |
9.54800000000366E-05 |
| Normal-vs-Asian |
1.875800E-01 |
| Caucasian-vs-AfricanAmerican |
5.655000E-01 |
| Caucasian-vs-Asian |
8.280400E-01 |
| AfricanAmerican-vs-Asian |
9.573800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.14899999806795E-08 |
| Normal-vs-Female |
6.808400E-02 |
| Male-vs-Female |
3.309700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.812000E-04 |
| Normal-vs-Extreme_Weight |
2.3264999999939E-05 |
| Normal-vs-Obese |
3.010300E-02 |
| Normal-vs-Extreme_Obese |
3.779300E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.969200E-01 |
| Normal_Weight-vs-Obese |
2.385000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.933000E-01 |
| Extreme_Weight-vs-Obese |
1.687160E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.926750E-01 |
| Obese-vs-Extreme_Obese |
5.636500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.832800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.165500E-02 |
| Normal-vs-Age(61-80Yrs) |
3.68289998498028E-09 |
| Normal-vs-Age(81-100Yrs) |
1.135330E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.715000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.738350E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.836290E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.577500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.706100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.102000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.403700E-04 |
| Normal-VS-Type2 PRCC |
9.35569999249708E-09 |
| Normal-VS-KIRP CIMP |
1.274090E-02 |
| Normal-VS-Unclassified PRCC |
7.824000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.076100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.151800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.208600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.428800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.996900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.477610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.998900E-04 |
| Normal-vs-N1 |
1.872380E-01 |
| Normal-vs-N2 |
1.594090E-04 |
| N0-vs-N1 |
2.355800E-01 |
| N0-vs-N2 |
4.855000E-01 |
| N1-vs-N2 |
2.338200E-01 |
|
|
